Literature DB >> 3558329

Ibuprofen can increase serum lithium level in lithium-treated patients.

M Ragheb.   

Abstract

The interaction between lithium and ibuprofen was studied in nine male patients admitted to the geropsychiatric ward of a veterans administration medical center. The patients, diagnosed as having bipolar affective disorder or schizoaffective disorder, who had been kept on a steady-state lithium level, received lithium for 3 days, then lithium and ibuprofen (1800 mg/day) for 6 days, and then lithium for 5 days. Ibuprofen increased the serum lithium level and decreased the lithium clearance with marked interindividual variations. These findings indicate that lithium dosage may need to be reduced in some patients following initiation of ibuprofen therapy. There was no significant correlation between changes in lithium serum level and creatinine clearance. The possibility that a tubular renal prostaglandin system may affect lithium excretion needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558329

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

1.  Tenidap sodium decreases renal clearance and increases steady-state concentrations of lithium in healthy volunteers.

Authors:  G Apseloff; K D Wilner; D A von Deutsch; N Gerber
Journal:  Br J Clin Pharmacol       Date:  1995       Impact factor: 4.335

Review 2.  Pharmacotherapy of bipolar disorder in children and adolescents: recent progress.

Authors:  Jonathan C Pfeifer; Robert A Kowatch; Melissa P DelBello
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

3.  Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam.

Authors:  D Türck; G Heinzel; G Luik
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 4.  Assessment and treatment of bipolar disorder in the elderly.

Authors:  J H Eastham; D V Jeste; R C Young
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

5.  PharmGKB summary: ibuprofen pathways.

Authors:  Liudmila L Mazaleuskaya; Katherine N Theken; Li Gong; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-02       Impact factor: 2.089

Review 6.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 7.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 8.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

Review 9.  Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs.

Authors:  Nicholas Moore; Charles Pollack; Paul Butkerait
Journal:  Ther Clin Risk Manag       Date:  2015-07-15       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.